Evidence map›Paper›PMID 41303646›Full record

ArticleInternational journal of molecular sciences2025

Endotoxin Pretreatment Mitigates Myocardial Ischemia-Reperfusion Injury Through Preservation of Mitochondrial Respiration: A Combined Assessment of In Vivo, Ex Vivo, and In Vitro Data.

Reverien Habimana, Jiae Seong, YeongEun Jo, Ryul-Hee Kim, Hyo-Jung Kim, Kyung Soon Choi, Mukhammad Kayumov, Francis O Obiweluozor, Wang-In Kim, Hwa Jin Cho and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Reverien HabimanaDepartment of Medical Science, Chonnam National University Graduate School, Gwangju 61469, Republic of Korea.ORCID 0000-0001-5324-6045
Jiae SeongExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
YeongEun JoExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Ryul-Hee KimExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Hyo-Jung KimExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Kyung Soon ChoiExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Mukhammad KayumovExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.ORCID 0000-0002-5533-3270
Francis O ObiweluozorExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Wang-In KimExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Hwa Jin ChoExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.ORCID 0000-0002-2458-8529
Dowan KimExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Kook Joo NaDepartment of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital and Medical School, Gwangju 61469, Republic of Korea.
Inseok JeongExtracorporeal Cardiopulmonary Innovation, Technology, and Education (EXCITE) Research Group, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.ORCID 0000-0002-2249-0667

Funding

Chonnam National University Hospital, Biomedical Research Institute BCRI24036Ministry of Trade, Industry and Energy RS-2023-00238181
6 · The paper itself

Abstract

Acute myocardial infarction is the most common form of coronary artery disease, and myocardial ischemia-reperfusion injury remains a major challenge despite advances in reperfusion therapy. Endotoxin preconditioning has been linked to reduced ischemia-reperfusion injury, but mechanisms remain unclear, and prior studies have used varied assessment methods with inconsistent results. In this study, we confirmed the protective effect of endotoxin preconditioning and assessed its role in preserving mitochondrial respiration using a multi-model approach of in vivo ischemia-reperfusion rat model, ex vivo normothermic rat heart perfusion, and in vitro hypoxia-reoxygenation in neonatal rat cardiomyocytes. Hemodynamic and cell-based analyses were performed in control (

Indexed as

EndotoxinsMitochondriaMitochondria, HeartMyocardial Reperfusion InjuryAnimalsCell RespirationDisease Models, AnimalHypoxia-Inducible Factor 1, alpha SubunitMaleMyocytes, CardiacOxidative StressOxygen ConsumptionRatsRats, Sprague-DawleyEndotoxinsHypoxia-Inducible Factor 1, alpha Subunitacute myocardial infarctionendotoxin pretreatmentischemia–reperfusion injurymitochondrial respiration

Identifiers

PMID41303646
PMCPMC12653926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.